Andrew E. Singer, EVP & CFO at Epizyme, Inc. (EPZM), sold 12,158 shares at $9.54 ($116K) on 2016-02-10, disclosed to the SEC on 2016-02-10.
Open-market sale of $116k EPZM by EVP & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EPZM | SELL | 2017-01-10 | $24K | — | Filing → |
| EPZM | SELL | 2016-12-12 | $11K | — | Filing → |
| EPZM | SELL | 2016-11-10 | $11K | — | Filing → |